Tobacco smoking is a risk factor for cancers of the liver and gastrointestinal (GI) tract, but the causal agents responsible for these cancers are uncertain. 2-Amino-9H-pyrido[2,3-b]indole (AαC) is an abundant heterocyclic aromatic amine present in tobacco smoke. AαC is a liver carcinogen and both a transgene mutagen and inducer of aberrant crypt foci in the colon of mice. We hypothesize that AαC may contribute to DNA damage and tumorigenesis in these organs of smokers. The potential of AαC to induce DNA adduct formation in liver, organs of the GI tract, lung, and urinary bladder, which are target organs of cancer in smokers, was examined using the C57BL/6 mouse as an animal model. AαC (400 or 800 ppm) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) (300 ppm), a liver and colon carcinogen in C57BL/6 mice, were given in the diet for up to 12 weeks. Liquid chromatography/mass spectrometry was employed to measure DNA adducts. The major DNA adducts of both carcinogens were identified as deoxyguanosine-C8 adducts. The levels of formation of AαC-and MeIQ-DNA adducts were similar in liver and extrahepatic tissues when adjusted for dose. The highest levels of adducts occurred in liver, followed by urinary bladder, and then in cecum and colon; lower DNA adduct levels were formed in the lung and pancreas following 12 weeks of feeding. The high levels of AαC adduct formed in liver, GI tract, and bladder of C57BL/6 mice reinforce the notion that AαC may contribute to DNA damage and cancer of these organs in smokers.
Tobacco smoking is a risk factor for lung and urinary bladder cancer but also for cancers of the oral cavity, larynx, liver, pancreas, and digestive tract (IARC, 2004 (IARC, , 2012 Giovannucci, 2001) . Tobacco-specific N-nitrosamines are thought to contribute to lung cancer, and aromatic amines are viewed as causal agents of bladder cancer in smokers, but the chemicals in tobacco associated with liver and digestive tract cancers are uncertain. A series of heterocyclic aromatic amines (HAAs) are formed during the cooking of meats and have been implicated as causal agents in the etiology of colorectal cancer (Sugimura et al., 2004) . Most of these HAAs are present at negligible levels in mainstream tobacco smoke (< 1 ng/cigarette) and unlikely to explain the elevated risk of liver and GI tract cancers in smokers. The HAA, 2-amino-9H-pyrido [4,3-b] indole (AαC), a pyrolysis product of protein, however, is present in main stream tobacco smoke at levels up to 258 ng/cigarette (Zhang et al., 2011) . These levels are 25-to 100-fold greater than the amounts of 4-aminobiphenyl (4-ABP) (Hoffmann, 1998) , an aromatic amine that has been implicated in the pathogenesis of bladder cancer in smokers (IARC, 2004 (IARC, , 2012 Recently, AαC was detected in the urine of individuals of the Shanghai cohort study (Turesky et al., 2007) . The number of cigarettes smoked per day was positively and significantly related to urinary levels of AαC, signifying that tobacco smoke is an important point source of AαC exposure.
4-ABP and 2-aminofluorene (2-AF), the most well studied among the carcinogenic aromatic amines (Kriek, 1992) , are bladder and liver carcinogens in rodents (Poirier and Beland, 1992) . In humans, one case-control study measured 4-ABP-DNA adducts, by immunohistochemistry methods, in hepatocytes of patients with hepatocellular carcinoma. A statistically significant increase in risk for hepatocellular carcinoma was reported with increasing levels of 4-ABP adducts (Wang et al., 1998) . Because cigarette smoking is a major source of exposure to 4-ABP in humans, this molecular epidemiologic study has strengthened the notion that tobacco smoke is a hepatic carcinogen in humans. Epidemiologic studies have also consistently reported that smoking is risk factor for colorectal cancer (IARC, 2004 (IARC, , 2012 Giovannucci, 2001; Gong et al., 2012) .
Apart from the endocyclic nitrogen atoms, AαC has the same chemical structure as 2-AF. AαC is a liver carcinogen in CDF1 toxicological sciences 133(2), 248-258 2013 doi:10.1093/toxsci/kft077 Advance Access publication March 27, 2013 mice (Sugimura et al., 2004) and both a potent lacI transgene colon mutagen and an inducer of aberrant crypt foci (ACF), early biomarkers of neoplasms, in the colon of C57BL/6 mice (Okonogi et al., 1997; Sugimura et al., 2004; Zhang et al., 1996) . The genotoxic potential of AαC in humans is not known; however, AαC readily undergoes metabolic activation by human hepatocytes to form the DNA adduct N- (deoxyguanosin-8-yl )-dG-C8-AαC (dG-C8-AαC) (Nauwelaers et al., 2011) , which is a mutagenic lesion .
The ability of chemical carcinogens to form DNA adducts is regarded as one important factor in their carcinogenic potential (Jarabek et al., 2009) . The C57BL/6 mouse has recently been used as a model for colorectal mutagenesis studies (Nagao et al., 2001) , and this mouse strain is more susceptible to intestinal carcinogenesis than the commonly used CDF1 mouse model for several classes of genotoxicants, including HAAs (Fujita et al., 1999; Ochiai et al., 2002) . There are no reports on dG-C8-AαC adduct formation in C57BL/6 mice. In this study, we investigated the potential of AαC to form DNA adducts in liver, organs of the digestive tract, lung, and urinary bladder, which are target organs of cancer in smokers, using the C57BL/6 mouse as an animal model. AαC was given in the diet for up to 12 weeks at dosages that induced lacI mutations in liver and colon and ACF in colon. The levels of AαC-DNA adduct formation were compared with those levels of adducts formed by 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ), an HAA formed in cooked meat and broiled fish (Kasai et al., 1980) . MeIQ undergoes bioactivation to form N-(deoxyguanosin-8-yl)-dG-C8-MeIQ as the principal adduct (Tada et al., 1994) , and MeIQ is a liver and colon carcinogen in C57BL/6 mice (Fujita et al., 1999) . The structures of AαC, MeIQ, and the arylamines, 4-ABP, and 2-acetylaminofluorene (2-AAF), the N-acetylated derivative of 2-AF, are shown in Figure 1 , and 4-ABP and 2-AAF are liver and bladder carcinogens in mice (Poirier and Beland, 1992) . (Bessette et al., 2009) .
MATerIALs AND MeThoDs

Caution
Oxidative studies on dG-C8-AαC and dG-C8-MeIQ. dG-C8-AαC and dG-C8-MeIQ (50 ng/0.1 ml) were oxidized under aerobic conditions at 50°C in (A) 1N NaOH for 2 h, followed by neutralization with an equal amount of Animal studies: DNA adduct formation in liver and extrahepatic tissues. Male and female C57BL/6J mice, 5-6 weeks of age, were purchased from Jackson Laboratories (Bar Harbor, ME). The use of these animals was in compliance with guidelines established by the National Institutes of Health Office of Laboratory Animal Welfare. Animals were housed four per cage with corn cob bedding in pathogen-free animal quarters of Research Animal Resources, University of Minnesota Academic Health Center. The mice were given a standard AIN-93G rodent diet containing 7% soybean oil (Dyets Inc., Bethlehem, PA) for 7 days. One week after arrival, the mice were switched to AIN-93G-powdered diet containing 13% Primex and 10% soybean oil. A high fat diet was previously used to induce ACF in AαC-treated mice (Okonogi et al., 1997; Sugimura et al., 2004; Zhang et al., 1996) . Mice of the treatment groups received AαC (400 or 800 ppm) or MeIQ (300 ppm) in the diet. These concentrations of carcinogens were previously used in long-term carcinogen studies and subchronic mutagenesis and ACF studies (Nagao et al., 2001; Sugimura et al., 2004; Zhang et al., 1996) . The carcinogens were mixed with the diet as follows: for 1 kg of diet, 180 g of casein was added to 720 g of AIN-93 G diet and mixed for 30 min using a diet blender (Fleetwood food equipment, Philadelphia, PA). Subsequently, the carcinogens were added, and the mixture was further mixed for 30 min. Finally, 100 ml of soybean oil (Dyets Inc.) was added and mixed for another 30 min. The diets were prepared every 4 weeks and stored in airtight plastic bags at 4°C. Chemical analysis, by LC/MS, showed that the carcinogens were stable in the diet over 4 weeks (R. Turesky, unpublished observations). The diet was administered using metal box feeders (Lab Products Inc., Seaford, DE). Fresh diet was provided every 3-4 days. Food consumption and body weight were monitored, respectively, twice a week and weekly. The average estimated daily food intake for male and female mice was, respectively, 3.1 and 3.2 g both for control and carcinogen-supplemented diets. The final body weights of the AαC-and MeIQ-treated animals were within 5% of the average body weights of untreated female mice and 10% of the average body weights of untreated male mice. The mice were euthanized by an overdose of carbon dioxide, and organs were harvested. The liver, lung, pancreas, and bladder were quickly excised, rinsed in cold saline, and snapped frozen in liquid nitrogen. The cecum and colon (ascending colon to the rectum) were cut longitudinally, washed in PBS, and then soaked for 15−20 min in PBS containing 1.5 mM EDTA, 3000 U heparin/l, DTT (80 mg/l), and PMSF (40 mg/l). Subsequently, the mucosal epithelial cell layer was scraped with a glass slide; epithelial cells were twice rinsed with chilled saline and then frozen in liquid nitrogen. 
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Isolation and enzymatic digestion of DNA. The entire liver, lung, pancreas, cecum, and colon were homogenized in TE buffer. The nuclear pellets were obtained by centrifugation at 3000 × g for 10 min. The equivalent of ~100 mg tissue from nuclear pellets of liver, lung, and pancreas and the entire nuclear pellets obtained from the cecum, colon, and bladder homogenates were used for DNA isolation. The DNA from nuclear pellets was isolated by the chloroform/phenol extraction method (Gupta, 1993) , except that the 2 mM ß-mercaptoethanol (ßME) was freshly added to the TE buffer.
DNA (10 μg) from animals, N = 4 per group, for all time points except for the 12-week time point, where there were two animals, was digested and analyzed in triplicate. For the case of bladder tissue, due to the limiting amount of material, DNA (2 µg) was digested and assayed in duplicate.
The internal standards [ 13 C 10 ]-dG-C8-AαC and [ 13 C 10 15 N 5 ]-dG-C8-MeIQ were added to DNA at a level of six adducts per 10 7 nucleotides prior to enzymatic digestion. The enzymatic hydrolysis of DNA was performed under conditions shown to be highly efficient in the recovery of HAA-DNA adducts (Nauwelaers et al., 2011) .
Ultraperformance liquid chromatography-electrospray ionization/ multistage mass spectrometry analyses of DNA adducts. Analysis was done with a NanoAcquity UPLC system (Waters Corporation, Milford, MA) interfaced with a linear quadrupole ion trap mass spectrometer (LTQ MS; Thermo Fisher, San Jose, CA), and an Advance CaptiveSpray source from Michrom Bioresources Inc. (Auburn, CA). A Waters Symmetry trap column (180 μm × 20 mm, 5 μm particle size) was employed for online solid-phase enrichment. The analytical column was a C18 AQ (0.3 × 150 mm, 3 μm particle size) from Michrom Bioresources (Auburn, CA). The DNA digests were injected onto the trap column and washed with 0.2% formic acid in 10% acetonitrile at a flow rate of 12 μl/min for 5 min. Thereafter, the DNA adducts were back-flushed onto the C18 AQ column. A linear gradient was employed to resolve the DNA adducts, starting at 0.01% formic acid containing 10% acetonitrile and arriving at 0.01% formic acid in 95% acetonitrile at 20 min. The flow rate was set at 5 μl/min.
Xcalibur version 2. The total ion counts were employed for measurement at the MS 3 scan stage. The mass spectral parameters were optimized as previously reported (Nauwelaers et al., 2011) . The characterization of HAA-DNA adducts and oxidation products was also performed by data-dependent constant neutral loss scanning, followed by acquisition of the triple-stage MS 3 (CNL/MS 3 ) spectra of the aglycone adducts as previously reported (Bessette et al., 2009) .
Statistical methods. Statistical differences between mean values of DNA adducts formed in specific organs were compared by one-way ANOVA, followed by Bonferroni's multiple comparison test for adduct levels in liver versus other organs. The comparison of mean levels of DNA adducts formed in liver of AαC-and MeIQ-treated mice at day 1 and day 7 was done by the Student's t-test. All statistical hypothesis testing was performed at the α = 0.05 significance level, and all statistical tests were two sided. Analyses were done with GraphPad Prism 4 software (San Diego, CA).
resuLTs
Identification of dG-C8-AαC and dG-C8-MeIQ Adducts in Mouse Liver and Oxidative Degradation of dG-C8-AαC During Sample Workup
The bioactivation of AαC and MeIQ is carried out by cytochrome P450 (P450) enzymes. Oxidation of the exocyclic amine group produces genotoxic N-hydroxy-HAA metabolites. These metabolites can directly react with DNA or undergo further metabolism by phase II enzymes, such as N-acetyltransferase (NAT) or sulfotransferase (SULT) to form esters, which are unstable and undergo heterolytic cleavage to produce the proposed reactive nitrenium ion that binds covalently to DNA (Turesky and Le Marchand, 2011) . The N-hydroxy metabolite of AαC also undergoes bioactivation by UDP-glucuronosyltransferases (UGT), a group of enzymes that are usually involved in detoxication of HAAs and aromatic amines (Tang et al., 2012) . The structures of dG-C8-AαC and dG-C8-MeIQ are shown in Figure 2 .
Our initial findings showed that the levels of dG-C8-AαC formation were highly variable in liver, and the estimates of adducts were not reproducible. We speculated that dG-C8-AαC had undergone oxidation during the isolation of the DNA. The dG-C8 adduct of 2-AF, N-(deoxyguanosin-8-yl)-2-AF (dG-C8-AF), which is very similar in structure to dG-C8-AαC, undergoes facile aerial oxidation of the guanine ring to form the spirodiasteroisomeric adducts containing an iminoimidazolidine-one moiety (Shibutani et al., 1990) . The guanyl moiety of dG-C8-AF can also undergo oxidation, followed by cleavage, to produce a ring-opened adduct containing the residual guanidino group of dG (Shibutani et al., 1990) . We surmised that dG-C8-AαC also underwent oxidation to form the same types of ring-opened adducts (Fig. 3) .
The ultraperformance liquid chromatography-electrospray ionization/multistage mass spectrometry (UPLC-ESI/MS 3 ) chromatograms of liver DNA digest from an untreated animal and DNA from an AαC-treated animal either without or with ßME added as an antioxidant during the isolation of DNA were monitored for dG-C8-AαC and its putative oxidation products (Fig. 4) . No adducts were detected in the chromatogram of the DNA digest from the untreated animal (Fig. 4A) , whereas low levels of dG-C8-AαC and peaks attributed to the ring-opened oxidation products of dG-C8-AαC were observed in the chromatogram of DNA isolated without ßME (Fig. 4B ). The addition of ßME (2mM) in the TE buffer prevented most of the oxidation of dG-C8-AαC and greatly suppressed the formation of the proposed oxidized adducts (Fig. 4C) .
The protonated molecular masses of the molecules are consistent with the formation of the spiroiminoimidazolidineone ([M+H] + at m/z 465.1) and ring-opened guanidino ([M+H] + at m/z 342.1) products of dG-C8-AαC. The product ion spectrum at the MS 2 scan stage of the proposed spiroiminoimidazolidineone adduct ([M+H] + at m/z 465.1) displayed a base peak ion at m/z 349.2, attributed to the loss of the deoxyribose (dR)
FIG. 3.
The proposed products formed from the aerial oxidation of dG-C8-AαC.
FIG. 4.
The UPLC-ESI/MS3 chromatogram of dG-C8 adducts of AαC and ring-opened oxidation products in liver DNA from (A) untreated mouse and DNA isolated with ßME, (B) mouse treated with AαC (800 ppm) for 4 weeks and DNA isolated without ßME, and (C) mouse treated with AαC (800 ppm) for 4 weeks and DNA isolated with ßME and (D) MS 3 scan stage product ion spectra of dG-C8-AαC (m/z 449.1 > 333.1 >), the proposed oxidized spiro-dG-C8-AαC (m/z 465.1 > 349.1 >), the proposed ring-opened guanidino derivative of dG-C8-AαC (342.1 > 226.1 >), and the MS 4 scan stage product ion spectrum of guanidino derivative of dG-C8-AαC (342.1 > 226.1 > 209.1 >).
AαC-AND MeIQ-DNA ADDUCT FORMATION IN MICE 251 moiety. The second generation product ion spectrum of adduct acquired on the ion at m/z 349.2 produced major fragment ions m/z at 290.2 and 252.1, attributed, respectively, to the losses of the guanidine (CH 5 N 3 ) and 2-imino-3,4-dihydroimidazol-4-one (C 3 H 3 N 3 O) moieties (Fig. 4D) . The product ion spectrum of the proposed guanidino adduct ([M+H] + at m/z 342.1) displayed a major ion at m/z 226.1, which is attributed to loss of dR. The second generation product ion spectrum of the adduct acquired on m/z 226.1 formed a base peak ion at m/z 209.1, attributed to loss of NH 3 (Fig. 4D) . The MS 4 scan stage spectrum acquired on the ion at m/z 209.1 showed fragment ions at m/z 167.1 and 185.1, which are attributed to the loss of cyanamide (CH 2 N 2 ) without or with a water cluster adducted to the deaminated AαC moiety. These product ion spectra are entirely consistent with the structures of the proposed ringopened oxidized adducts of dG-C8-AαC. Synthetic dG-C8-AαC also underwent decomposition in NaOH or H 2 O 2 to form the same two oxidized adducts. The CNL/MS 3 data-dependent scanning experiments monitoring for the loss of dR (116.1 Da) as a neutral species showed that these two ring-opened adducts were the sole oxidation products of dG-C8-AαC ( Supplementary Fig. S-1) .
Three other isomeric dG-AαC adducts were detected (labeled as peaks 1-3 in Fig. 4B ). These adducts did not undergo noticeable oxidation during sample workup of DNA in the absence of ßME. Assuming similar ionization efficiencies, the levels of these isomeric dG-AαC adducts occur at several percentage or less of the level of dG-C8-AαC when DNA is isolated with ßME (Fig. 4C) . The product ion spectra of these adducts are suggestive of dG-N 2 adducts, but assignments of structures could not be unambiguously established. In contrast to the instability of dG-C8-AαC, dG-C8-MeIQ does not undergo facile oxidation. Comparable levels of dG-C8-MeIQ were measured in DNA samples, irrespective of the addition of ßME as an antioxidant during the isolation of DNA (Fig. 5) . The data-dependent CNL/ MS 3 scan mode monitoring the loss of dR (116.1 Da) as a neutral fragment was conducted on liver DNA, but only dG-C8-MeIQ was detected (data not shown). Representative UPLC-ESI/MS 3 chromatograms of colon and bladder DNA adducts of AαC and MeIQ are shown in Supplementary figure S-2.
FIG. 5. The UPLC-ESI/MS
3 chromatogram of dG-C8-MeIQ in liver DNA from (A) untreated mouse and DNA isolated with βME, (B) mouse treated with MeIQ (300 ppm) for 4 weeks and DNA isolated without βME, and (C) mouse treated with MeIQ (300 ppm) for 4 weeks and DNA isolated with βME and and (D) MS 3 stage product ion spectrum of dG-C8-MeIQ.
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Kinetics DNA Adduct Formation of dG-C8-AαC and dG-C8-MeIQ in Liver and Extrahepatic Tissues of Mice
The levels of DNA adduct formation in liver, pancreas, lung, colon, cecum, and bladder are tabulated in Tables 1 and 2 . The concentrations of adducts formed in the different tissues following 1 day and 1 week of feeding are shown in Figure 6 , and the kinetics of adduct formation during the entire course of the study are depicted in Figure 7 . The comparison of DNA adduct formation of AαC and MeIQ following a single day of treatment versus continuous feeding for 12 weeks revealed striking differences between adduct formation and persistence in certain tissues. After a single day of treatment, the liver contained the highest levels of AαC DNA adducts among all of the organs measured, followed by the colon and cecum. In contrast, MeIQ adduct formation was highest in colon and cecum, followed by liver, after 1 day of dosing. The liver became the primary organ for DNA adduct formation of MeIQ following 1 week of dose treatment. By the end of the 12-week feeding study, DNA adducts accumulated in a number of tissues: the urinary bladder contained the second highest levels of DNA adducts after the liver for both HAAs, followed by cecum, colon, pancreas, and lung in mice of both genders. Gender differences were observed between the mean adduct levels of AαC formed in liver during the first week of feeding: higher adduct levels were observed in female liver at 1 day and 1 week of the 400-ppm diet (p < 0.01) and at 1 week of the 800-ppm diet (p < 0.03). Higher adduct levels were also formed for MeIQ in female liver than in male liver at 1 week of feeding (p < 0.01). Given the small number of animals (N = 4) and large doses, these modest ~1.3-fold differences in hepatic DNA adduct formation between genders should be interpreted with caution.
The level of dG-C8-AαC reached an optimum in liver by 1 week and 4 weeks of feeding, respectively, in female and mice. Thereafter, the adduct levels declined over time, particularly in the high dose-treated animals. The level of dG-C8-MeIQ in liver reached a peak by 8 weeks of feeding and remained constant for the duration of the study (Fig. 7) . The dG-C8-AαC adduct reached a steady-state level in the urinary bladder by ~1 week and 4 weeks of treatment, respectively, for male and female mice (Fig. 7) . The level of dG-C8-MeIQ adduct formation in bladder was lower than the level of dG-C8-AαC during the first week of treatment, but surpassed the concentration of dG-C8-AαC, when adjusted for dose, after 1 month of feeding.
The cecum contained comparable levels of DNA adducts for both AαC and MeIQ (Fig. 7) . The level of dG-C8-AαC was greater than the amount of dG-C8-MeIQ in the colon during the first week of treatment, but the amount of dG-C8-MeIQ surpassed the level of dG-C8-AαC during prolonged dosing. The adduct levels of both carcinogens varied by about two-to threefold in the large intestine during the 12-week feeding.
Pancreas and lung tissue harbored the lowest levels of DNA adducts. When adjusted for dose, dG-C8-MeIQ adduct formation was greater than dG-C8-AαC at most time points. dG-C8-AαC adduct formation reached a steady state at Notes. Data of each time point are the average and SD of four animals, except for week 12, where two animals were assayed. Each organ from each animal was assayed in triplicate, except for bladder, where two measurements were done, and *lung, where the average and SD were obtained from one animal with three independent measurements of DNA adducts. Notes. Data of each time point are the average and SD of four animals, except for week 12, where two animals were assayed. Each organ from each animal was assayed in triplicate, except for bladder, where two measurements were done.
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FIG. 6.
DNA adduct formation of AαC and MeIQ in liver, bladder, colon, cecum, pancreas, and lung of male and female C57BL/6 mice following 1 day and 1 week of dose treatment. The one-way ANOVA p values for the mean DNA adduct levels of AαC and MeIQ in liver and extrahepatic tissues of both genders for both doses and time points were p < 0.001. Bonferroni's multiple comparison test revealed that the mean level of dG-C8-AαC was elevated and significantly different in liver versus all other organs for both genders at day 1 and week 1 (p < 0.001). The mean level of dG-C8-MeIQ was also elevated and significantly different in liver versus all other organs at week 1(p < 0.001). The mean levels of dG-C8-MeIQ in colon of males and colon and cecum of females were significantly higher than the adduct level in liver, whereas lower levels of dG-C8-MeIQ were formed in pancreas, lung, and bladder (females only) than in liver of both genders at day 1 (**p < 0.01; ***p < 0.001).
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TANG ET AL. ~1 month in both organs, whereas the levels of dG-C8-MeIQ continued to increase in pancreas and lung throughout the 12-week feeding.
DIsCussIoN
HAAs and aromatic amines undergo bioactivation or detoxication by P450 enzymes and phase II enzymes, including NAT, SULT, and UGT expressed in liver and extrahepatic tissues, but with markedly different enzyme kinetic parameters Turesky and Le Marchand, 2011) . Differences in enzyme biotransformation pathways are likely to affect relative levels of adducts formed and influence the potential target tissues of tumorigenesis by HAAs and aromatic amines Turesky and Le Marchand, 2011) . Several aromatic amines present in tobacco smoke have been implicated in the pathogenesis of bladder cancer in smokers (IARC, 2012) . Interestingly, some epidemiology studies have reported that high intakes of red meat, well-done meat, and consumption of HAAs is associated with an increased risk in the development of bladder cancer ( (Lin et al., 2012) and references within).
Clear differences in the kinetics of DNA adduct formation were observed for both AαC and MeIQ. In the case of AαC, the dG-C8-AαC adduct is preferentially removed in the liver compared with other tissues; however, the efficiency of adduct removal/repair may be concentration dependent or require a threshold level of DNA adducts. Indeed, the rate of removal of dG-C8-AαC in liver was greater in mice dosed with 800 ppm AαC than in mice treated with 400 ppm of AαC, and comparable levels of dG-C8-AαC were present in the liver at both dosages at the end of the 12-week feeding. Alternatively, subchronic administration of AαC may have altered the expression of carcinogen metabolism enzymes in liver and diminished the P450-mediated N-oxidation or augmented phase II detoxication pathways, resulting in diminished hepatic DNA adduct levels over time. In contrast to dG-C8-AαC, the adduct concentrations of dG-C8-MeIQ reached a steady-state level in the liver, bladder, pancreas, and lung either by 4 weeks or continued to increase during the course of the study.
The amounts of AαC and MeIQ adducts were higher in the colon and cecum compared with other extrahepatic tissues examined during the first week of feeding. Because of the rapid cell turnover in cecum and colon (Westra et al., 1985) , DNA adducts of AαC and MeIQ did not accumulate in the large intestine (Fig. 7) . However, dG-C8-AαC or dG-C8-MeIQ adducts can induce mutations during the high rate of DNA synthesis and cell division taking place in the stem cells of the large intestine, and these cells may rapidly proliferate to produce ACF and tumors more readily than the cells of the liver or other slowly dividing tissues containing DNA adducts of AαC and MeIQ (Nagao et al., 2001) .
FIG. 7.
Kinetics of DNA adduct formation of AαC and MeIQ over 12 weeks in liver, bladder, colon, cecum, pancreas, and lung of male and female C57BL/6 mice. Data of each time point are the average and SD of four animals, except for week 12, where two animals were assayed. Data of each animal were assayed in triplicate, except for bladder, where two independent measurements were done.
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Female C57BL/6 mice develop tumors of the colon, cecum, and liver when given a diet containing 300 ppm of MeIQ (Fujita et al., 1999) . Carcinogenicity studies have not been conducted with AαC in C57BL/6 mice, but CDF1 mice developed liver and blood vessel tumors when given a diet containing 800 ppm of AαC (Sugimura et al., 2004) . The Big Blue mouse has the genetic background of C57BL/6, and both MeIQ and AαC induced high levels of mutants in the lacI transgene in the liver and colon of this mouse strain (Nagao et al., 2001; Zhang et al., 1996) . The majority of the lacI mutations reported in the colon were base substitutions. Approximately 50% of the total number of mutations induced by both HAA adducts were G:C to T:A transversions although the mutations occurred at different sequence contexts of the lacI gene (Nagao et al., 2001; Zhang et al., 1996) . C57BL/6 mice also form ACF when treated with AαC (500 or 800 ppm), and more than half the ACF clustered in the region about 20-40% of the distance from the ileocecal portion of the large intestine (Okonogi et al., 1997) . Under a similar dosing regimen, our LC/MS measurements show that dG-C8-AαC adduct formation ranged between ~several adducts up to 14 adducts per 10 7 DNA bases in cecum and colon during the 12-week feeding study. Thus, this level of dG-C8-AαC adduct formation appears sufficient to induce lacI transgene mutations and ACF in the colon of C57BL/6 mice.
The bladder contained the second highest levels of DNA adducts, following the liver, in mice treated subchronically with either AαC or MeIQ. The high level of DNA adducts formed in bladder was unexpected because studies conducted on other structurally related HAAs in mice or nonhuman primates reported very low levels of adduct formation in bladder in comparison to other organs (Nerurkar et al., 1995; Snyderwine et al., 1988 Snyderwine et al., , 1994 . Some aromatic amines cause bladder and liver cancer in rodents.
Subchronic dosing studies showed that 4-ABP and 2-AAF formed up to ~10-fold higher levels of DNA adducts in liver and bladder of BALB/c mice (Poirier and Beland, 1992) than the adduct levels formed in these organs of C57BL/6 mice treated with AαC or MeIQ. However, the metabolism of these structurally related class of chemicals and the covalent binding potencies may be different in these mouse strains. In the case of 4-ABP, the carcinogen was administered in the water supply rather than the diet, and the bioavailability of 4-ABP may be higher than when given in the diet. The levels of 4-ABP and 2-AAF DNA formation were linearly correlated to dose and tumorigenesis in liver of BALB/c mice although the relationship was markedly nonlinear in bladder. The investigators noted that DNA adduct formation was insufficient for bladder tumorigenesis, and other factors, such as cell proliferation, were required to develop bladder tumors (Poirier and Beland, 1992) . Moreover, gender differences in bladder tumor formation were observed, and female mice were refractory toward 4-ABP treatment (Poirier et al., 1995) . Cell proliferation has also been reported to be a critical factor in the development of cancer of the colon and prostate in rodents exposed to the structurally related HAA 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) (Cheung, et al., 2011 , Li, et al., 2012 .
MeIQ was one of the first of the HAAs discovered in cooked foods. MeIQ was identified in well-done broiled sardines and beef extract (Kasai et al., 1980) , but MeIQ has rarely been found at appreciable levels in commonly cooked meats, poultry, or fish staples of the western diet (Felton et al., 2000) , and the contribution of MeIQ to the daily burden of exposure to HAAs appears to be minor. In contrast to MeIQ, the exposure to AαC is widespread. AαC arises in mainstream tobacco smoke (Zhang et al., 2011) and diesel exhausts (Manabe et al., 1991) , and AαC can form in meats cooked very well done (Holder et al., 1997) . However, cigarette smoking is thought to be a major point source of exposure to AαC (Turesky et al., 2007) . Although the lung contained the lowest levels of AαC-DNA adducts of the organs measured in mice when AαC was given as part of the diet, the route of administration may greatly affect the level of AαC-DNA adduct formation in different organs. A future study will examine AαC-DNA adduct formation in lung and other organs via inhalation to better simulate exposure to AαC from smoking.
DNA adducts are thought to play a critical role in the development of cancer by genotoxic carcinogens (Jarabek et al., 2009) , but DNA adduct formation alone is insufficient for tumorigenesis (Poirier and Beland, 1992) . As reported by Nagao et al. (2001) , the cell turnover kinetics of mutated cells might be different in different organs. Also, differences in transcription-coupled repair capacity among different organs and the number of genetic alterations required for cancer development may be different in different organs. All of these factors are likely to impact the incidence of tumorigenesis in different organs. Given the high levels of DNA adduct formation by AαC, combined with the induction of lacI mutations in liver and colon, and the occurrence of ACF in colon of C57BL/6 mice, long-term studies are warranted to determine whether liver, the GI tract, or possibly bladder are target organs of AαC-mediated carcinogenicity in this mouse strain.
Epidemiologic studies conducted over the past two decades have consistently shown that tobacco smoking is a risk factor for cancers of the GI tract (IARC, 2004 (IARC, , 2012 Giovannucci, 2001; Gong et al., 2012) . There is also mounting evidence that tobacco smoke is an independent risk factor for hepatocellular carcinoma, the predominant form of human liver cancer (IARC, 2012) . Moreover, the risk of developing colorectal cancer is increased in smokers who harbor rapid phenotype for both NAT2 and P450 1A2 (Le Marchand et al., 2002; Nöthlings et al., 2009) ; both enzymes are involved in the bioactivation of AαC (Turesky and Le Marchand, 2011) . The high levels of AαC present in tobacco coupled with its efficient bioactivation by liver and extrahepatic tissues of the C57BL/6 mouse and by human liver to form DNA adducts (Nauwelaers et al., 2011; Tang et al., 2012) provide a biochemical mechanism and a plausible role for AαC in tobacco-associated cancers of the liver and digestive tract of smokers. Molecular epidemiology studies investigating the role of AαC in tobacco-associated cancers are warranted.
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